EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

Barriers to and facilitators of implementing the Lebanese Health Economic Evaluation Guideline: An initial exploration

Caroline Daccache, Mickaël Hiligsmann, Silvia M A A Evers, Rana Rizk, Rita Karam

Expert Review of Pharmacoeconomics & Outcomes Research · 2025

DOI: 10.1080/14737167.2025.2559092 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Expert Review of Pharmacoeconomics & Outcomes Research, 2025. Verfasst von Caroline Daccache und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Faculty of Health Medicine and Life Sciences, Maastricht …. Hauptthemen laut MEDLINE: Decision Making, Technology Assessment, Biomedical, Guidelines as Topic, Health Policy. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Pharmacoeconomics and Outcomes Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To identify the major barriers to and facilitators of implementing the Lebanese Health Economic Evaluation Guideline (LEEG) according to Lebanese stakeholders, supported by their insights.‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬. METHODS: We conducted a survey asking 16 key stakeholders to rate LEEG's importance, its necessity for Lebanon, and its applicability in decision-making, and Likert scale questions to rate barriers and facilitators. Following the survey, an individual face-to-face interview using open-ended questions was arranged to validate the survey's data, to collect further insights regarding LEEG's implementation in Lebanon, and to identify relevant barriers and facilitators. RESULTS: All participants considered LEEG to be very important for Lebanon. The majority considered it very important for decision-making, while there was some disagreement on the applicability of economic evaluation as a criterion for decision-making. The most important barriers were 'lack of political willingness to adopt economic evaluation and use health technology assessment findings' and 'the absence of policy networks.' The most important facilitators were 'the strong need to implement national guidelines in Lebanon' and 'acceptability to payers.' CONCLUSION: We reported on important barriers to and facilitators of implementing LEEG related to the national context and methodological concerns. This will pave the way for developing strategies essential for effective implementation and, consequently, a better healthcare system, advancing progress to universal health coverage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Decision MakingTechnology Assessment, BiomedicalGuidelines as TopicHealth PolicyLebanonHumansSurveys and QuestionnairesCost-Benefit AnalysisInterviews as TopicStakeholder Participation

Stichwörter der Autor:innen

LEEGLebanonbarrierseconomics pharmaceuticalfacilitatorsguidelinelow- and middle-income countriespolicy making

Autor:innen und Institutionen

  • Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
  • Department of Public Health, Faculty of Health Sciences, University of Balamand, Balamand, Lebanon.
  • Department of Nutrition and Food Science, School of Arts and Sciences, Lebanese American University, Byblos, Lebanon.
  • Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban (INSPECT-LB), Beirut, Lebanon.
  • Faculty of Sciences and Medical Sciences, Lebanese University, Hadath, Lebanon.

Förderung

  • Pharmacoeconomics and Outcomes Research

Zitieren

APA

Daccache, C., Hiligsmann, M., Evers, S. M. A. A., Rizk, R., & Karam, R. (2025). Barriers to and facilitators of implementing the Lebanese Health Economic Evaluation Guideline: An initial exploration. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2025.2559092

Vancouver

Daccache C, Hiligsmann M, Evers SMAA, Rizk R, Karam R. Barriers to and facilitators of implementing the Lebanese Health Economic Evaluation Guideline: An initial exploration. Expert Review of Pharmacoeconomics & Outcomes Research. 2025. doi:10.1080/14737167.2025.2559092

BibTeX
@article{Daccache2025,
  author = {Daccache, Caroline and Hiligsmann, Mickaël and Evers, Silvia M A A and Rizk, Rana and Karam, Rita},
  title = {Barriers to and facilitators of implementing the Lebanese Health Economic Evaluation Guideline: An initial exploration},
  journal = {Expert Review of Pharmacoeconomics & Outcomes Research},
  year = {2025},
  doi = {10.1080/14737167.2025.2559092}
}
Kostenlos starten →